← SynDRA
ANIRACETAM
SynDRA canonical compound SYN0001968 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | HTR2A |
|---|
| Mechanism of action | Glutamate receptor agonist |
|---|
All known targets
- DRD2
- GRIA1
- GRIA2
- GRIA3
- HTR2A
- GRIA4
Mechanisms of action (all sources)
- Glutamate receptor agonist
- GRIA1 POSITIVE ALLOSTERIC MODULATOR
- GRIA2 POSITIVE ALLOSTERIC MODULATOR
- GRIA3 POSITIVE ALLOSTERIC MODULATOR
- GRIA4 POSITIVE ALLOSTERIC MODULATOR
- DRD2 INHIBITOR
- HTR2A INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- MAOA
- NPY1R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MBNL1
- MAPT
- MAPK3
- MAPK14
- MAPK1
- LCK
- NR1I2
- KDM4E
- KCNH2
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR1A
- HRH3
- HRH2
- HRH1
- HMGCR
- HDAC6
- NPY2R
- NR3C1
- ADORA1
- SAMHD1
- USP1
- THRB
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- STAT3
- SLC6A4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ARRB1
- CP1A2
- CP2C9
- CP2CJ
- E2AK3
Drug classes
- Antidepressive Agents
- Central Nervous System Agents
- Nootropic Agents
- Psychotropic Drugs
ATC classes
- N06B · PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
Cross-references
Synonyms
- ampamet
- draganon
- memodrin
- 1-p-anisoyl-2-pyrrolidinone
- Ampamet
- Draganon
- Memodrin
- Sarpul
- NSC-758223
- RO-13-5057
- RO-135057
- 1-(4-Methoxybenzoyl)-2-pyrrolidinone
- 1-(4-methoxybenzoyl)pyrrolidin-2-one
- 1-p-Anisoyl-2-pyrrolidinone
- Ro-13-5057
- Aniracetamun [INN-Latin]
- Aniracetam [USAN:INN:JAN]
- UNII-5L16LKN964
- Ro 135057
- BRN 4807205
- 1-p-anisoylpyrrolidin-2-one
- 2-Pyrrolidinone, 1-(4-methoxybenzoyl)-
- CHEMBL36994
- MLS000079240
- CHEBI:47943
- 1-(p-Methoxybenzoyl)-2-pyrrolidinon [German]
- ZXNRTKGTQJPIJK-UHFFFAOYSA-N
- 5L16LKN964
- NCGC00015116-10
- SMR000038438
- 1-anisoyl-2-pyrrolidinone
- NSC 758223
- DTXCID3025128
- 1-[(4-methoxyphenyl)carbonyl]pyrrolidin-2-one
- 1-((4-methoxyphenyl)carbonyl)pyrrolidin-2-one
- aniracetamum
- RefChem:558129
- N06BX11
Look up ANIRACETAM in the interactive SynDRA portal →